Blood-brain barrier modeling: challenges and perspectives
Main Authors: | Tobias Ruck, Stefan Bittner, Sven G Meuth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=6;spage=889;epage=891;aulast=Ruck |
Similar Items
-
Fingolimod (FTY720-P) Does Not Stabilize the Blood–Brain Barrier under Inflammatory Conditions in an in Vitro Model
by: Michael K. Schuhmann, et al.
Published: (2015-12-01) -
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
by: Tobias Ruck, et al.
Published: (2015-07-01) -
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
by: Tobias Brummer, et al.
Published: (2021-08-01) -
Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management
by: Stefan Bittner, et al.
Published: (2017-01-01) -
Targeting ion channels for the treatment of autoimmune neuroinflammation
by: Stefan Bittner, et al.
Published: (2013-09-01)